<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-22T10:10:06Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/105134" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/105134</identifier>
        <datestamp>2023-07-11</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_14789</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_14788</setSpec>
        <setSpec>com_2142_8903</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:contributor>Hergenrother, Paul J.</dc:contributor>
          <dc:contributor>Hergenrother, Paul J.</dc:contributor>
          <dc:contributor>Mitchell, Douglas A.</dc:contributor>
          <dc:contributor>van der Donk, Wilfred A.</dc:contributor>
          <dc:contributor>Zimmerman, Steve C.</dc:contributor>
          <dc:creator>Garcia, Alfredo</dc:creator>
          <dc:date>2019-08-23T20:44:31Z</dc:date>
          <dc:date>2019-08-23T20:44:31Z</dc:date>
          <dc:date>2021-08-24T09:15:16Z</dc:date>
          <dc:date>2019-02-20</dc:date>
          <dc:date>2019-05</dc:date>
          <dc:description>The continual rise of microbial resistance is a pressing concern throughout the world, resulting in several thousands of deaths each year. Most of these deaths are a result of Gram-negative infections as no new class of Gram-negative antibiotics has been introduced in several decades. The problematic nature of this epidemic lies in the composition of the Gram-negative bacterial membrane, as it is impermeable to most organic small-molecules. The eNTRy rules, developed by the Hergenrother lab, can guide the synthesis of Gram-negative-active antibiotic leads as they predict the likelihood of compound accumulation in Gram-negative bacteria. In general, for a compound to accumulate in Gram-negative bacteria, it must possess an ionizable nitrogen, be relatively flat, and rigid. A major hurdle to this approach is installation of the nitrogen without disturbing target engagement. A solution to this involves appendage of ionizable nitrogens on a prodrug moiety such that it crosses the outer membrane and is cleaved within Gram-negative bacteria, releasing the active antibiotic. Such novel strategy can be a powerful approach to combat disease-causing pathogens as it addresses the major limitation of discovering new broad-spectrum antibiotics: passage across the outer membrane, and ultimately accumulation.
The chapters herein emphasize the importance of combating antibiotic resistance, specifically against Gram-negatives, and provide actionable strategies by which to accomplish this mission. Chapter 1 focuses on the challenges of generating Gram-negative actives and describes novel solutions to this problem. This chapter also describes the structure-activity relationship of Gram-positive only antibiotic fusidic acid. Chapter 2 discusses the ring distortion of the alkaloid sinomenine using the complexity-to-diversity (CtD) approach to generate 66 total compounds, which played a key role in identifying the 3-dimensionality parameter, globularity (Glob), as important for accumulation in Gram-negative bacteria, and eventual discovery of the eNTRy rules. Chapter 3 describes our initial efforts to convert fusidic acid using the eNTRy rules and then describes the success of this conversion target using a novel polyamine amidoxime ester prodrug strategy.</dc:description>
          <dc:description>Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2021-05-01</dc:description>
          <dc:description>The student, Alfredo Garcia, accepted the attached license on 2019-02-18 at 12:18.</dc:description>
          <dc:description>The student, Alfredo Garcia, submitted this Dissertation for approval on 2019-02-18 at 13:25.</dc:description>
          <dc:description>This Dissertation was approved for publication on 2019-02-20 at 10:04.</dc:description>
          <dc:description>DSpace SAF Submission Ingestion Package generated from Vireo submission #13392 on 2019-08-22 at 16:19:50</dc:description>
          <dc:description>Made available in DSpace on 2019-08-23T20:44:31Z (GMT). No. of bitstreams: 4
GARCIA-DISSERTATION-2019.pdf: 19739036 bytes, checksum: b4a2572b30eef71e7a60deeb9b464e23 (MD5)
Alfredo Garcia Dissertation.docx: 31151227 bytes, checksum: 0dfcd439201cc5c156ec5507d08fa983 (MD5)
LICENSE.txt: 4211 bytes, checksum: 44918534f68ba590859ee0cbf0d72bfb (MD5)
PROQUEST_LICENSE.txt: 4557 bytes, checksum: 0eb9566d18d6f1df875231021c008c35 (MD5)
  Previous issue date: 2019-02-20</dc:description>
          <dc:description>Embargo set by: Seth Robbins for item 112253
Lift date: 2021-08-23T20:44:50Z
Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system</dc:description>
          <dc:description>Embargo set by: Seth Robbins for item 112253
Lift date: 2021-08-23T20:46:41Z
Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system</dc:description>
          <dc:description>Embargo set by: Seth Robbins for item 112253
Lift date: 2021-08-23T20:47:38Z
Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system</dc:description>
          <dc:description>Embargo set by: Seth Robbins for item 112253
Lift date: 2021-08-23T20:48:32Z
Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system</dc:description>
          <dc:description>Limited Restriction Lifted for Item 112253 on 2021-08-24T09:15:16Z.</dc:description>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>http://hdl.handle.net/2142/105134</dc:identifier>
          <dc:language>en</dc:language>
          <dc:rights>Copyright 2019 Alfredo Garcia</dc:rights>
          <dc:subject>Ring distortion</dc:subject>
          <dc:subject>sinomenine</dc:subject>
          <dc:subject>fusidic acid</dc:subject>
          <dc:subject>prodrug</dc:subject>
          <dc:subject>broad-spectrum antibiotic</dc:subject>
          <dc:title>Ring distortion of the alkaloid sinomenine and novel prodrug approaches to broad-spectrum antibiotics</dc:title>
          <dc:type>text</dc:type>
          <dc:type>text</dc:type>
          <degree>
            <department>Chemistry</department>
            <discipline>Chemistry</discipline>
            <grantor>University of Illinois at Urbana-Champaign</grantor>
            <level>Dissertation</level>
            <name>Ph.D.</name>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
